Esperion Therapeutics reported $6.51M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US USD 5.02B 880M
Alnylam Pharmaceuticals ALNY:US USD 41.12M 308K
Amarin AMRN:US USD 23.94M 11.87M
Amgen AMGN:US USD 1.59B 78M
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Daiichi Sankyo 4568:JP JPY 84.77B 9.97B
Eli Lilly And LLY:US USD 1.58B 148.6M
Esperion Therapeutics ESPR:US USD 6.51M 2.67M
Halozyme Therapeutics HALO:US USD 47.32M 13.38M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Intercept Pharmaceuticals ICPT:US USD 424K 115K
Intra Cellular Therapies ITCI:US USD 5.85M 1.2M
IONIS PHARMACEUT IONS:US USD 1.52M 3.23M
Merk MRK:US USD 3.43B 715M
Moderna Inc MRNA:US USD 1.1B 281M
Nektar Therapeutics NKTR:US USD 4.97M 143K
Pfizer PFE:US USD 6.09B 2.58B
Ptc Therapeutics PTCT:US USD 14.01M 4.37M
Puma Biotechnology PBYI:US USD 12.5M 2.42M
Regeneron Pharmaceuticals REGN:US USD 317.8M 20.7M
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Seattle Genetics SGEN:US USD 108.12M 2.02M
United Therapeutics UTHR:US USD 37.2M 7.5M
Vanda Pharmaceuticals VNDA:US USD 6.32M 261K